Stock listing
ABSI Stock Price, News, Filings & Events — Absci Corporation
Selected listing: ABSI · NASDAQ · USD · US
This page tracks Absci Corporation's ABSI:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABSI:NASDAQ. ABSI:NASDAQ is the stock-level entry point for investors researching Absci Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Absci Corporation, trading under the ticker ABSI, is a publicly listed company in the American market with a market capitalization of approximately $1.28 billion. The company focuses on advancing its innovative technologies in the biotechnology sector. Absci aims to enhance drug discovery and development processes through its proprietary platform.
- Ticker
- ABSI:NASDAQ
- Asset type
- Stock
- Market cap
- $1.49B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Absci Corporation ABSI:NASDAQ stock context
This page tracks Absci Corporation's ABSI:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABSI:NASDAQ. ABSI:NASDAQ is the stock-level entry point for investors researching Absci Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Absci Corporation, trading under the ticker ABSI, is a publicly listed company in the American market with a market capitalization of approximately $1.28 billion. The company focuses on advancing its innovative technologies in the biotechnology sector. Absci aims to enhance drug discovery and development processes through its proprietary platform.
Latest news from Absci Corporation
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
July 14, 2026
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
June 24, 2026
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the...
June 12, 2026
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
May 7, 2026
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
April 23, 2026
Absci Corporation earnings calls
Absci Corporation (ABSI) Q2 2026 Earnings Call
August 11, 2026 · Replay with transcript and chapters
Absci Corporation (ABSI) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Absci Corporation (ABSI) Q4 2025 Earnings Call
March 24, 2026 · Replay with transcript and chapters
Absci Corporation (ABSI) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
Absci Corporation (ABSI) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Absci Corporation (ABSI) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Absci Corporation
Absci Corporation investor report
Review AI stock analysis and investor report context for ABSI:NASDAQ.
Absci Corporation company profile
View the public company page for Absci Corporation on 6ix.
Absci Corporation news
Read company news and market updates connected to Absci Corporation.
Absci Corporation investor events
Find investor webinars, events, and replay context for Absci Corporation.